Vision-Integrity-Engineering near Navin MB (214 Result(s))

Jones Goodridge are manufacturer's representatives proudly serving Canada's Midwest plumbing and heating industry for the past 25 years. We are pleased to bring our uncompromising commitment to quality service to some of the industry's leading manufacturers. Through our investment in people, we believe our integrity and collective years of experience enhance our shared vision of old fashioned service with a smile.

Looking to buy a car in Steinbach? At Ledingham GM, we sell a large selection of new and used vehicles all at outstanding rates. Come visit us Highway 12 North or give us a call to learn more.

OUR FOUNDING PRINCIPLES - We are created in the image of God and endowed with dignity and infinite worth. We are redeemed through Jesus Christ that we might belong to God forever. God has embraced the whole world in loving care. The congregation of Christ Lutheran Church wishes to provide a channel whereby love, born through faith in Christ, may be made visible and be directed to the service of all people.1081 Andrews St, Wpg, MB R2V 2G9 Phone: (204) 338-4641 Fax:(204) 338-4643Luther Home Facilities

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.

Meditek's Small BeginningsMeditek ,A centrally located in Winnipeg, MB, entered the Canadian medical industry in 1981.As a division of the family corporation that had been operating since 1962, Meditek was poised to provide nationwide support.A small service department was created in a little workshop with the vision of remanufacturingAmedical equipment .Today, Meditek still offers that same quality service of remanufacturing, even though we have diversified into many other areas of medical products and services.Defining Meditek's LegacyMeditek's core belief in reliability, quality and customer service remains unchanged. We carry these values forward every day.As we developed, we recognized that Canadian hospitals wanted and deserved better medical equipment conditions in their operating rooms.A This realization led to distribution growth of new medical equipment and products for a variety of manufacturers.At the same time, we continued to provide cost-effective medical equipment solutions for budget restrained hospitals in Canada through our unique remanufacturing program.Committed to remain the total solutions partner, Meditek's product development will never cease as we continuously develop new healthcare products and services to meet the requirements of tomorrow

Saving Lives Through Early Disease DiagnosisMiraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.The Miraculins AdvantageProducts & ProgramsMiraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.